Abstract
Gene transfer into skeletal muscle cells by direct injection of naked plasmid DNA results in sustained gene expression. Intramuscular injection of plasmid DNA might thus be used to correct myopathies, to secrete locally or systematic therapeutic proteins and to elicit an immune response against specific antigens. However, the potential utility of this technique for gene application in humans is limited by the poor transduction efficiency and the low and highly variable level of gene expression. Different methods are thus being developed to increase the efficiency of gene transfer in muscles. It has been recently reported that a dramatic improvement of DNA transfer is achieved by applying an electric field to the muscle fibers subsequent to local DNA injection. Electro-gene-transfer increases gene expression by several orders of magnitude and strongly reduces interindividual variability. Electroinjection of genes encoding for secreted proteins resulted in sustained expression and disease correction in animal models of gene therapy. Moreover, the immunogenicity of DNA vaccines is dramatically increased when antigen-encoding plasmids are delivered by this technique. This technique may thus have broad and important applications in human gene therapy. This review provides a brief overview of the theory of electro-gene-transfer and describes parameters governing its efficiency in muscle. We also summarize the results obtained with electro-gene-transfer in animal models to date and the technical issues that must be solved before its use for human therapy can be considered.
Similar content being viewed by others
References
Wolff JA, Malone RW, Williams P et al. Science 1990; 247:1465–1468.
Wolff JA, Ludtke JJ, Acsadi, G et al. Hum Mol Genet 1992; 1:363–369.
Van Deutekom JCT, Hoffman EP, Hueard, J. Mol Med Today 1998; 4:214–220.
Rizzuto G, Cappelletti M, Maione D et al. Proc Natl Acad Sci USA 1999; 96:6417–6422.
Horn AN, Meek JA, Budahazi G et al. Hum Gene Ther 1995; 6:565–573.
Svensson EC, Tripathy SK, Leiden JM. Mol Med Today 1996; 2:166–172.
Engel AG, Yamamoto M, Fischbeck KH. In Myology, AG Engel, C Franzini-Armstrong (eds.), McGraw-Hill, New York, 1994, pp. 1133–1187.
Nabel G, Felgner PL. Trends Biotechnol 1993; 11:211–215.
Cohen AD, Boyer JD, Weiner DB. FASEB J 1998; 12:1611–1626.
Doh SG, Vahlsing HL, Hartikka J et al. Gene Ther 1997; 4:648–663.
Kitsis RN, Buttrick PM, McNally EM et al. Proc Natl Acad Sci USA 1991; 88:4138–4142.
Jiao S, Williams P, Berg RP et al. Hum Gene Ther 1992; 3:21–33.
Vitadello M, Schiaffino WV, Picard A et al. Hum Gene Ther 1994; 5:11–18.
Dupuis M, Denis-Mize K, Woo C et al. J Immunol 2000; 165:2850–2858.
Liu M, McClements W, Ulmer J et al. Vaccine 1999; 17:909–912.
Wang R, Doolan DL, Le TP et al. Science 1998; 282:476.
MacGregor RR, Boyer JD, Ugen KE et al. J Infect Dis 1998; 178:92.
Calarota S, Bratt G, Nordlund S et al. Lancet 1998; 351:1320.
Alila H, Coleman M, Nitta H et al. Hum Gene Ther 1997; 8:1785–1795.
Hartikka J, Sawdey M, Cornefert-Jensen F et al. Hum Gene Ther 1996; 7:1205–1217.
Baranov A, Glazkov P, Kiselev A et al. Gene Ther 1999; 6:1406–1414.
Li X, Eastman EM, Schwarts RJ et al. Nat Biotech 1999; 17:241–245.
Mumper RJ, Duguid JG, Khursheed A et al. Pharm Res 1996; 13:701–709.
Anwer K, Earle KA, Shi M et al. Pharm Res 1999; 16:889–895.
Lemieux P, Guerin N, Paradis G e al. Gene Ther 2000; 7:986–991.
Singh M, Briones M, Ott G et al. Proc Natl Acad Sci USA 2000; 97:811–816.
Aihara H, Miyazaki J. Nat Biotech 1998; 16:867–870.
Mir LM, Bureau MF, Gehl J e al. Proc Natl Acad Sci USA 1999; 96:4262–4267.
Mathiesen I. Gene Ther 1999; 6:508–514.
Neumann E, Schaefer-Ridder M, Wang Y et al. EMBO J 1982; 1:841–845.
Chu G, Hayakawa H, Berg P. Nucleic Acids Res 1987; 15:1311.
Andreason GL, Evans GA. Biotechniques 1988; 6:650–660.
Weaver JC, Chizmadzhev YA. Biolectrochem Bioenerg 1996; 41:135–160.
Neumann E, Kakorin S, Toesing K. Biolectrochem Bioenerg 1999; 48:3–16.
Jaroszeski MJ, Gilbert R, Nicolau C et al. Adv Drug Deliv Rev 1999; 35:131–137.
Teissie J, Rols MP. in Charge and Field Effects in Biosystems-3, MJ Allen, SF Cleary, AE Sowers, D Shillady (eds.), Birkhauser Press, Boston.
Lurquin PF. Mol Biotechnol 1997; 7:5–35.
Lee RC, Canady DJ, Hammer SM. J Burn Care Rehabil 1993; 5:529–539.
Gehl J, Mir L. Biochem Biophys Res Comm 1999; 261:377–380.
Gehl J, Thyge H, Sorensen H et al. Biochim Biophys Acta 1999; 1428:233–240.
Vicat JM, Boisseau S, Jourdes P et al. Hum Gene Ther 2000; 11:909–916.
Bettan M, Emmanuel F, Darteil R et al. Mol Ther 2000; 2:204–210.
Rizzuto G, Cappelletti M, Mennuni C et al. Hum Gene Ther 2000; 11:1891–1900.
Kreiss P, Bettan M, Crouzet J et al. J Gene Med 1999 1:245–250.
Maruyama H, Sugawa M, Moriguchi Y et al. Hum Gene Ther 2000; 11:429–437.
Abruzzese RV, Godin D, Mehta V et al. Mol Ther 2000; 2:276–287.
Abruzzese RV, Godin D, Burcin M et al. Hum Gene Ther 1999; 10:1499–1507.
Widera G, Austin M, Rabussay D et al. J Immunol 2000; 164:4635–4640.
Martin T, Parker SE, Hedstrom R et al. Hum Gene Ther 1999; 10:759–768.
Kadowaki S, Chen Z, Asanuma H et al. Vaccine 2000; 18:2779–2788.
Zucchelli S, Capone S, Fattori E et al. J Virol 2000; 74:11598–11607.
Bureau MF, Gehl J, Deleuze V et al. Biochim Biophys Acta 2000; 1474:353–359.
Stacy BD, Thorburn GD. Science 1996; 152:1076–1077.
Draghia-Aki R, Fiorotto ML, Anne Hill L et al. Nat Biotech 1999; 17:1179–1183.
Cole KS. Membranes, Ions and Impulses, University of California Press, Berkeley, 1972.
Selby M, Goldbeck C, Pertile T et al. J Biotechnol 2000; 83:147–152.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fattori, E., Monica, N.L., Ciliberto, G. et al. Electro-Gene-Transfer: A New Approach for Muscle Gene Delivery. Somat Cell Mol Genet 27, 75–83 (2002). https://doi.org/10.1023/A:1022927822244
Issue Date:
DOI: https://doi.org/10.1023/A:1022927822244